Cabaletta Bio Inc (NASDAQ: CABA) kicked off on Friday, up 8.44% from the previous trading day, before settling in for the closing price of $2.37. Over the past 52 weeks, CABA has traded in a range of $0.99-$5.46.
Annual sales at Healthcare sector company slipped by -20.35% over the past five years. While this was happening, its average annual earnings per share was recorded 5.74%. With a float of $84.43 million, this company’s outstanding shares have now reached $96.27 million.
Cabaletta Bio Inc (CABA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cabaletta Bio Inc is 12.29%, while institutional ownership is 64.76%.
Cabaletta Bio Inc (CABA) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.65 earnings per share (EPS), lower than consensus estimate (set at -0.63) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.99% during the next five years compared to -20.35% drop over the previous five years of trading.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Take a look at Cabaletta Bio Inc’s (CABA) current performance indicators. Last quarter, stock had a quick ratio of 3.60. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.53, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.79 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
Cabaletta Bio Inc (NASDAQ: CABA) saw its 5-day average volume 2.62 million, a positive change from its year-to-date volume of 2.25 million. As of the previous 9 days, the stock’s Stochastic %D was 69.56%.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 54.36%, which indicates a significant decrease from 82.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was higher than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.51, while its 200-day Moving Average is $1.86. Nevertheless, the first resistance level for the watch stands at $2.73 in the near term. At $2.88, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.08. If the price goes on to break the first support level at $2.38, it is likely to go to the next support level at $2.18. The third support level lies at $2.03 if the price breaches the second support level.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
The company with the Market Capitalisation of 247.40 million has total of 96,265K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -115,860 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -44,870 K.
